Cannabics Pharmaceuticals, Inc.
(Other OTC/NBB : CNBX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.53%74.150.0%$2393.32m
NVAXNovavax, Inc. 4.67%175.3299.2%$1265.25m
SRNESorrento Therapeutics, Inc. 6.32%14.471.8%$570.88m
GILDGilead Sciences, Inc. 0.26%68.991.0%$550.76m
AMGNAmgen, Inc. -0.50%240.341.3%$482.95m
REGNRegeneron Pharmaceuticals, Inc. 0.74%625.822.5%$439.89m
BNTXBioNTech SE 0.60%77.540.0%$396.78m
VRTXVertex Pharmaceuticals, Inc. 0.29%274.131.9%$376.26m
BIIBBiogen, Inc. 9.46%303.921.6%$342.57m
VXRTVaxart, Inc. 4.34%9.490.0%$297.70m
ILMNIllumina, Inc. -13.93%343.703.5%$276.15m
EBSEmergent BioSolutions, Inc. 1.89%129.366.4%$179.29m
ALXNAlexion Pharmaceuticals, Inc. -0.59%103.291.9%$169.16m
SGENSeattle Genetics, Inc. -0.58%160.866.0%$164.85m
IBIOiBio, Inc. -4.43%3.880.2%$162.08m

Company Profile

Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.